In addition to brain biopsies, the company’s robotic technology is applicable in the brain for shunt placements and neurostimulation electrode placement such as for deep brain stimulation.

Mazor Robotics CEO Ori Hadomi said, "While our core is spine surgery, we are thrilled that our technology can be expanded to improve other surgical procedures."

Regulatory clearance for the brain application is pending in the US and Europe.

Upon regulatory clearance, the brain application will be available as an add-on to the company’s Renaissance system at a separate price point expected early 2013.